The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
Surgical site infections can be prevented during pain relief procedures, anesthesiologists and pain physicians say.
In multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and publishe ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to ...
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent. This is shown by the largest survey ...